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ASSESSMENT OF TEXAS MEDICAL PROVIDERS CONCERNING RABIES 
VACCINES 
 
DENISE M. RUFFINO, USDA, APHIS, Wildlife Services, San Antonio, TX, USA 
SCOTT E. HENKE, Caesar Kleberg Wildlife Research Institute, Texas A&M University-
Kingsville, Kingsville, TX, USA 
 
Abstract:  Rabies is an important zoonotic disease in Texas and thousands of people each year 
either request or require rabies prophylaxis because they have ‘high risk’ jobs or are exposed to 
the disease.  After experiencing difficulty in receiving rabies prophylaxis from physicians, we 
conducted a survey of Texas medical providers to assess their knowledge of rabies vaccine 
procedures and their experience with rabies vaccines.  Most providers in Texas (>95% of 297) 
rarely saw patients for rabies prophylaxis; therefore, providers have minimal, if any, experience 
with the procedures of acquiring and administering the vaccine.  Providers varied greatly in their 
responses to our questions of where to acquire the vaccine, how and where to administer the 
vaccine, and where to acquire information about the vaccine.  State and local health departments 
should target medical clinics and physician associations as outlets to disseminate information 
regarding rabies, rabies prophylaxis, and treatment. 
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INTRODUCTION 
 Rabies is an important zoonotic viral 
disease in the United States that causes an 
acute encephalitis, which if left untreated, 
has a prognosis that is almost always fatal.  
Epizootics of rabies have been reported in 
raccoons (Procyon lotor) along the Atlantic 
coastal states (Hanlon et al. 1989), in red fox 
(Vulpes vulpes) from northeastern states 
(Johnston et al. 1988), in striped skunks 
(Mephitis mephitis) from central states 
(Rupprecht et al. 1996), in coyotes (Canis 
latans) in southern Texas (Farry et al. 
1998a, b), in gray fox (Urocyon 
cinerargenteus) in central Texas (Steelman 
et al. 2000), and in bats sporadically 
throughout the continental United States 
(Rupprecht et al. 1996).   
 Human exposure to rabies has 
occurred in each epizootic.  Every year 
approximately 16,000 - 39,000 people in the 
United States receive post-exposure rabies 
prophylaxis (Krebs et al. 1998).  In addition, 
pre-exposure rabies vaccinations should be 
offered to persons in high-risk groups, such 
as veterinarians, animal handlers, wildlife 
biologists, etc.  Pre and post-exposure rabies 
prophylaxis is routinely available with a 
physician’s prescription.  However, 
knowledge of physicians as to the process to 
acquire rabies vaccine (i.e., pre and post 
exposure) is uncertain.  We became 
involved in this issue when we had difficulty 
in acquiring pre-exposure rabies vaccine for 
ourselves and employees.  Medical 
providers we contacted in Texas either 
denied services, were hesitant, or unsure 
how to acquire rabies prophylaxis.  
Therefore, our objectives were to compare 
knowledge of medical providers concerning 
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rabies vaccines between physicians whose 
practice was located within and outside 
historic Oral Rabies Vaccination Program 
(ORVP) baiting zones in Texas, and to 
compare knowledge of medical providers 
concerning rabies vaccine between small 
and large cities within Texas.  Houston, 
Dallas/Ft.Worth, and Austin contain large 
concentrations of skunk and bat rabies 
endemic in those populations and for which 
ORVP is not available.  Due to mass media, 
we have included them inside the rabies 
zone, although no bait has ever been placed 
there.  Our hypothesis was that medical 
providers whose practices occurred within 
the rabies ORVP zones would potentially 
have more requests for pre and post-
exposure rabies vaccines; therefore, would 
be more familiar with procedures for 
acquiring and administering rabies 
prophylaxis.  
 
METHODS 
 Medical providers were contacted 
throughout Texas and either the physician or 
nurse was interviewed concerning their 
knowledge of rabies prophylaxis and post 
exposure vaccine.  Since many insurance 
companies require an initial visit to a 
primary care physician, medical providers 
surveyed were limited to those in family 
practice.  Medical providers were placed 
into one of four categories: either within or 
outside the rabies endemic zone and either 
in a small (<60,000 population) or large 
(>100,000 population) city.  Rabies endemic 
zone was defined as areas that occurred 
within the historic bait drop zones for 
coyotes, gray foxes, and skunks in Texas 
(Bradley Hicks, USDA-APHIS-WS, 
personal communication).  Medical 
providers were randomly selected from the 
yellow page listings from cities that met our 
size stipulation.  Medical provider selection 
continued until 10 clinics were interviewed 
from each city, unless that city had fewer 
clinics that were willing to participate.  
Medical providers that occurred in small 
cities within the rabies endemic zone 
included offices in Raymondville/Port 
Isabelle (N = 7), Junction (N = 10), 
Fredericksburg (N = 10), Fort Stockton (N = 
5), Harlengen (N = 6), Kingsville (N = 10), 
Kerrville (N = 10), and Stephenville (N = 
10); medical providers that occurred in large 
cities within the rabies endemic zone 
included offices in McAllen (N = 10), 
Laredo (N = 10), Austin (N = 10), San 
Antonio (N = 10), Houston (N = 10), Dallas 
(N = 10), Ft. Worth (N = 10), Abilene (N = 
10), and Corpus Christi (N = 10); medical 
providers that occurred in small cities 
outside the rabies endemic zone included 
offices in Corsicana (N = 9), Galveston (N = 
10), San Marcos (N = 10), Lufkin (N = 10), 
Georgetown (N = 10), Bay City (N = 10), 
and Victoria (N = 10); medical providers 
that occurred in large cities outside the 
endemic rabies zone included offices in 
Wichita Falls (N = 10), Amarillo (N = 10), 
Lubbock (N = 10), El Paso (N = 10), 
Midland (N =10), Odessa (N = 10), and 
Waco (N = 10) (Figure 1).  Physicians or 
nurses were asked a series of questions 
concerning rabies pre-exposure and post 
exposure vaccines (Table 1), and their 
responses were recorded. 
 Answers of respondents were 
analyzed using G-tests (Sokal and Rohlf 
1981) to compare the mean proportion of 
categorical responses given between 
respondents by region (inside or outside the 
rabies endemic zone), city size (large or 
small), and interactions of main effects.  
Statistical tests were considered significant 
at P < 0.05.   Unless otherwise specified, 
data were pooled and graphically 
represented due to non-significant 
differences between regions and city sizes. 
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Figure 1.  Locations of medical providers who participated in our survey of rabies vaccines.  Red stars are 
cities within the rabies endemic zone; yellow stars are outside the rabies endemic zone; big-sized stars 
represent large cities (>100,000 population); small-sized stars represent small cities (<60,000 population). 
 
Table 1.  Survey questions asked of Texas physicians concerning pre and post exposure rabies vaccines. 
1. Do you administer pre-exposure rabies vaccine? 
2. Do you administer post exposure rabies vaccine? 
3. Why do you not administer pre-exposure rabies vaccine? 
4. Why do you not administer post exposure rabies vaccine? 
5. Where can a person get pre-exposure rabies vaccine? 
6. Where can a person get post exposure rabies vaccine? 
7. Is the pre-exposure rabies vaccine a single shot or a shot series? 
8. Is the post exposure rabies vaccine a single shot or a shot series? 
9 If a series, how many shots are in the pre-exposure series? 
10. If a series, how many shots are in the post exposure series? 
11. Where on the body are the rabies pre-exposure vaccines given? 
12. Where on the body are the rabies post exposure vaccines given? 
13. What side effects can occur with rabies pre-exposure vaccines? 
14. What side effects can occur with rabies post exposure vaccines? 
15. Are pre-exposure vaccines kept in stock or ordered on an individual basis? 
16. Are post exposure vaccines kept in stock or ordered on an individual basis? 
17. To how many patients did you administer pre-exposure rabies vaccine in the last year?  Last 5 years? 
18. To how many patients did you administer post exposure rabies vaccine in the last year?  Last 5 years? 
19. Where would one get information about rabies vaccines? 
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RESULTS 
 Three hundred forty-four clinics 
were contacted, of which 297 medical 
providers participated in our survey.  Of the 
47 non-participatory clinics, a greater 
number (x2 = 17.1, df =3, P <0.001) of 
medical providers were from large cities 
outside the rabies endemic area (75% of the 
chi-square value) than the remaining regions 
and city sizes. 
 Significant interactions occurred 
between regions and city sizes (x2 > 9.3, df 
=3, P <0.03) when medical providers were 
asked how many patients they administered 
pre and post exposure rabies vaccine to 
during the last year and past 5 years.  More 
medical providers from small cities within 
the rabies endemic area treated more 
patients with rabies prophylaxis than 
medical providers from the other regions 
and city sizes (Figure 2a-d).  However, the 
majority of medical providers (>95%) did 
not have a history of rabies prophylaxis 
treatment.  Significant differences between 
region, city size, and interactive effects were 
not noted (x2 < 6.0, df =3, P > 0.14) for the 
remaining questions of our survey. 
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Figure 2(a).  Percent of respondents (N=297) who stated that they treated patients with pre-exposure rabies 
prophylaxis during the last year.  No differences were observed between respondents within and outside 
rabies endemic zone, city size, or interactive effects. 
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Figure 2(b).  Percent of respondents (N=297) who stated that they treated patients with pre-exposure rabies 
prophylaxis during the last 5 years.  The same capital letter within each category for patient number is not 
different (P > 0.05). 
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Figure 2(c).  Percent of respondents (N=297) who stated that they treated patients with post exposure rabies 
vaccine during the last year.  The same capital letter within each category for patient number is not different 
(P > 0.05). 
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Figure 2(d).  Percent of respondents (N=297) who stated that they treated patients with post exposure rabies 
vaccine during the last 5 years.  The same capital letter within each category for patient number is not 
different (P > 0.05). 
 
In general, medical providers had 
varied responses to our questions.  Nearly 
70% of the 297 medical providers stated that 
they would provide post exposure rabies 
vaccine to patients; however, only 52% 
responded that they also would administer 
the pre-exposure prophylaxis.  Answers 
varied as to why medical providers (N = 
143) did not administer pre-exposure 
prophylaxis (Figure 3), but the majority of 
medical providers that would not give post 
exposure vaccines (58% of 92) stated that 
they had no authority to administer the 
vaccine (Figure 3).  Of the same medical 
providers who would not administer rabies 
prophylaxis, when asked where a person 
could acquire rabies vaccines, the majority 
of providers responded that patients should 
go to county health offices (41.8% of 143) 
and hospitals (66.3% of 92) for pre-exposure 
and post exposure rabies vaccines, 
respectively (Figure 4).  Of the medical 
providers who did provide rabies vaccines to 
their patients, only 1 of 154 providers 
maintained the pre-exposure vaccine in 
stock while the vast majority of providers 
ordered the vaccine on an ‘as needed’ basis.  
All medical providers who were willing to 
provide post exposure vaccine to their 
patients (N = 205) ordered the vaccine on an 
‘as needed’ basis.  When asked if the pre-
exposure rabies vaccines was a single 
injection or a series of injections, 33.3% and 
48.1% of the medical providers said the 
vaccine was a single shot and shot series, 
respectfully, while the remaining providers 
either did not know or chose to not respond 
to the question.  When the same question 
was posed concerning the post exposure 
vaccine, 0% and 81.8% of the medical 
providers said the vaccine was a single shot 
and shot series, respectfully, while the 
remaining 18.2% of the providers did not 
know or chose to not answer the question.  
Of the medical providers who responded 
that rabies prophylaxis was a series of 
injections, 23.9%, 24.2% and 51.9% of the 
providers (N = 143) stated that the pre-
exposure vaccine was a series of 2-5 shots, 
6-9 shots, and ‘did not know’, respectfully, 
while 0.7%, 31.0%, and 68.3% of the 
providers (N = 243) stated that the post 
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exposure vaccine was a series of 2-5 shots, 
6-9 shots, and ‘did not know’, respectfully.  
The majority of medical providers believed 
that pre-exposure vaccines are administered 
in the arm of patients, while the stomach 
was considered the injection site of choice 
for post exposure shots by more providers 
(Figure 5).  Responses by medical providers 
concerning the side effects of pre and post 
exposure vaccines varied widely (Figure 6).  
Lastly, when asked where a person should 
go to acquire information about rabies 
vaccines, 18.2% responded their family 
physician, 60.3% said the county health 
department, 21.4% said the state health 
department, and 0.4% of the 297 medical 
providers responded that they did not know.  
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Figure 3.  Reasons given why certain medical providers did not provide pre and post exposure rabies vaccines 
to their patients. 
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Figure 4.  Places suggested by medical providers who would not provide pre and post exposure vaccines to 
their patients as to where the patients could acquire the rabies vaccine. 
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Where on the body are pre- and post exposure vaccines given?
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Figure 5.  Injection site locations suggested by medical providers as to where on the body pre and post 
exposure rabies vaccines should be given. 
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Figure 6.  Side effects suggested by medical providers that can potentially occur after pre and post exposure 
rabies vaccines are given. 
 
DISCUSSION 
 Despite its rarity in our modern 
culture, rabies still invokes a deep fear.  
Since antiquity, rabies has been one of the 
most feared diseases (Jackson 2002).  Many 
of these fears were played out before our 
eyes as some of our movie and television 
heros fought the good fight before 
succumbing to rabies, usually occurring 
during western-themed genre.  Even Roy 
Rogers died of rabies in his last movie role 
as a predator trapper on a large Texas ranch.  
Little wonder then that many envision rabid 
dogs in rural areas when considering rabies.  
This ingrained lesson may be partially 
responsible for our observance of statistical 
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significance regarding the number of 
physicians from small cities/within the 
established rabies zones willing to give pre 
and post exposure vaccinations to residents, 
when compared to all other groups.  Other 
reasons might include expanded media 
coverage of rabies dues to rabies control 
activities occurring within and around their 
town, observed economic boosts to the local 
economy as rabies control activities are 
conducted in their area, and recognition by 
local doctors of zoonotic disease concerns 
present within the vicinity.  Additionally, 
enhanced awareness of wildlife and wildlife 
issues by residents of small cities, typically 
more tied to the land as compared to large, 
metropolitan areas, may create a very small, 
but continuous demand for rabies treatment.  
Figure 3 depicts this small, but steady 
demand as observed in the number of shots 
given across all categories in the last 5 
years. 
 
Pre-Exposure Vaccination 
 The World Health Organization 
(WHO 2002) states that pre-exposure rabies 
vaccination should be given to groups of 
persons at high risk of exposure to live 
rabies virus, including laboratory staff, 
veterinarians, animal handlers, wildlife 
officers, and others who’s hobbies may 
expose them to rabies.  Pre-exposure 
prophylaxis is beneficial for the following 
reasons:  1) the need for rabies immune 
globulin is eliminated, 2) post-exposure 
vaccine regimen is reduced from five to two 
doses, 3) protection against rabies is 
possible if post-exposure treatment (PET) is 
delayed, 4) protection against inadvertent 
exposure to rabies is possible, and 5) the 
cost of PET is reduced (Briggs 2002).  In 
spite of these easily obtained findings, 
roughly half of all respondents indicated that 
they did not offer pre-exposure propholaxis.  
Reasons given were unexpected at best and 
totally confusing at worst.  Of those 
providers not offering pre-exposure 
treatment, insurance liability (25.2%) and 
the lack of authority to give these shots 
(24.9%) were cited as the leading reasons, 
with difficulty in getting vaccine coming in 
third (7.1%). 
 Liability is a concern when 
providing most any service, especially if the 
service is considered an elective procedure.  
Given that rabies exposure is sometimes 
achieved without the awareness of the 
individual, classifying pre-exposure 
vaccination as “elective”, and thereby not 
readily available, could prove fatal to those 
with any risk for exposure.  As with all 
prescription drugs available legally in the 
US, rabies vaccine is manufactured under 
FDA regulations and given FDA approval as 
safe when used as directed.  Briggs (2002) 
reported that while allergic reactions have 
been reported after booster vaccination, a 
maintenance requirement for maintaining 
pre-exposure protection, no serious or 
lasting medical conditions developed.  All 
have been treated successfully with 
antihistamines, epinephrine, and steroids.  
Exactly why medical facilities would look at 
rabies vaccine differently from any other 
prophylaxes, such as tetanus vaccine, is 
unclear and needs to be further studied 
within the legal arena.   
 More puzzling is the feeling that 
medical providers did not have the authority 
to give pre-exposure rabies vaccine.  As a 
prescription drug, only doctors can prescribe 
it.  Many medical providers cited the need to 
contact local and state health department 
officials for assistance.  After calling a small 
random sample of county health 
departments, several said that they could 
assist in administering the shot series.  
However, no department had a doctor on 
staff to prescribe the shot series, thus leaving 
the first essential step of prescribing the 
vaccination to doctors.  All county and state 
health officials expressed surprise at the “no 
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authority” response and restated their role as 
a support role, not the leading force in 
controlling disease at the ground level.   
 Difficulty in obtaining the vaccine 
was identified as a reason not to offer the 
vaccination series.  In reality, pre-exposure 
vaccine is kept in stock and available at all 
state health regional offices and many 
county health offices across the state (Tom 
Sidwa, Texas Dept. of Health personal 
communication 2005).  Additionally, 
vaccine can be ordered from the 
manufacturer directly by toll free numbers 
supplied by state heath officials and listed 
on the Centers for Disease Control (CDC) 
website (www.cdc.gov/ncidod/dvrd/rabies/ 
professional/professi.htm).  CDC also offers 
a 24 hours a day/7 days a week information 
line for physicians, nurses, pharmacists, 
veterinarians, and other health officials that 
have questions about rabies and rabies 
prophylaxis. 
 
Post-Exposure Treatment 
 Rabies is a unique neurologic 
infection that can be prevented by PET, at 
least when the vaccine is administered to 
patients within a reasonable period of time 
after a rabies exposure (Lafon 2002).  
However, nearly one-third of our 
respondents did not offer PET. A shocking 
60% felt they had no authority to administer 
the treatment regimen followed by an 
equally shocking response by 26.9% that 
they did not have time.  These attitudes are 
not particularly helpful to someone that has 
been exposed to rabies, a potentially fatal 
disease. 
 As stated earlier, it is difficult to 
understand exactly how doctors came to 
believe they have no authority to prescribe a 
vaccine to combat a medical condition.  
Whether this is specific to rabies or extends 
to other diseases is unknown.  However, it is 
particularly troubling given the urgent need 
for medical care.  Both WHO (2002) and 
CDC (2005) state that rabies vaccine therapy 
should be initiated as soon as possible, 
following exposure.  Furthermore, WHO 
considers PET to constitute an emergency 
situation.  While emergency care and initial 
shots can be initiated at most hospital 
emergency rooms, it is important to note that 
rabies vaccines are very expensive.  CDC 
(2003) estimated the cost of a course of 
rabies immune globulin and five doses of 
vaccine given over a 4 week period typically 
exceeds $1000.  Wound care, tetanus shot, 
and any additional antibiotics needed are in 
addition to this figure.  Added costs 
associated with emergency room care could 
quickly and easily exceed an individual’s 
available funds.  Given rabies’ life 
threatening potential, health care is a 
necessity and availability of treatment at 
one’s primary health care facility could help 
substantially reduce the associated financial 
burden. 
 Every potential rabies exposure 
should be evaluated on a case-by-case basis, 
considering the epidemiology of the area, 
species involved, type of contact between 
victim and suspected rabid animal 
(provoked vs. unprovoked), and the 
anatomical location and severity of exposure 
(Briggs 2002).  Need for medical treatment 
or non-treatment could then be evaluated 
from these results.  While this procedure 
may take some time away from the usual 
stream of common ailments, it can not be 
stressed enough of the potential death of a 
patient exposed to rabies.  Of our 
respondents surveyed who did not treat 
patients possibly exposed to rabies, 26.9% 
claimed they did not have time to treat them.  
Although not specially asked as to the 
meaning of the statement, it is assumed that 
the amount of time researching necessary 
procedures and vaccine procurement would 
seriously hamper their ability to provide 
health care for all patients.  Recognition and 
utilization of associated consulting staff at 
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local and/or state health departments, as well 
as CDC’s rabies support hotline, would 
greatly reduce the time burden possibly felt 
by uninformed health care providers. 
 The percentage of providers who did 
not treat rabies exposures seem consistent 
with the number of providers that gave 
incorrect answers to how rabies vaccinations 
are given.  Results in Figure 5 showed that 
while most providers understood rabies 
treatments (pre and post-exposure) were 
given as a series of shots, most were 
confused as to where the shots were given.  
Older vaccines were given in a variety of 
locations, including the stomach region.  In 
1980, a new vaccine was licensed by FDA 
for use in rabies treatment in the US 
(Vodopija and Clark 2000).  Currently, all 
vaccine is given in the deltoid region of the 
arm for adults and can be administered in 
the thigh area for children.  Our results 
indicated that over half (58.2%) believed 
that PET was still given in the stomach, 
while 22.6% believed them to be given in 
the gluteus.  WHO (2002) stated that neither 
the pre nor post-exposure shots should ever 
be given in the gluteal region and Briggs 
(2002) added that shots in the gluteal area 
may lead to lower antibody levels and 
failure of PET.  Ironically, a recent San 
Antonio new story told of a south Texas 
child, exposed to a rabid animal, as facing a 
series of shots in the stomach (Gary Nunley, 
USDA-APHIS-WS, personal commun-
ication 2005).  Even after 25 years, the 
perceived discomfort of shots in the stomach 
is apparently hard to remove from the 
American psyche. 
 Lastly, when asked where one should 
go to get information about rabies vaccines, 
81.7 % indicated that either state or county 
health departments could provide this 
information.  Only 18.2% respondents felt 
one could get information from their family 
physician.  Consistent with our findings, 
family doctors may indeed be the last place 
one should attempt to get information about 
this important disease.  To resolve 
confusion, information packets need to be 
developed and distributed to family 
physicians.  Aided by a quick reference, 
medical personnel could cut their research 
time significantly, disseminate correct 
information to the patient, and be guided by 
experts when making important rabies 
treatment decisions.  To spare expense, hard 
copies could be distributed periodically, 
with the Texas Department of Health’s 
website serving as the appropriate place to 
get up to date information between hard 
copy printings.  Information sharing 
between health officials and physicians is 
paramount to adequately protecting Texas 
residents from this rare, but ever present 
disease. 
 
CONCLUSION 
 Rabies is endemic in several wildlife 
species in Texas, making human exposure a 
rare, but real threat to human life.  Many 
residents, not educated in the disease, its 
prevention, and/or its treatment, are 
dependent on their medical providers to 
provide swift and complete medical 
treatment.  Unfortunately, our survey 
indicated that many primary care medical 
personnel throughout Texas are equally 
deficient in their knowledge of the virus, 
resulting in a serious reduction of treatment 
outlets for exposure cases.  A state-wide 
educational program, targeted at medical 
providers, needs to be implemented to 
increase awareness of rabies prophylactic 
procedures and treatment. 
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